Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.
Pipeline
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen® to identify novel compounds that target and kill CSCs.


News
&
Events
8/14/2014
Stemline Provides Second Quarter 2014 Financial Results And Corporate Update
8/5/2014
Stemline to Present at the Wedbush Life Sciences Management Access Conference
7/28/2014
Stemline Announces Opening of SL-401 IND and Start of Trials in BPDCN and AML
Copyright 2014 - Stemline Therapeutics, Inc. All rights reserved
Stemline